title: What's new with stress ulcer prophylaxis in the ICU?
authors.affiliation: Department of Intensive Care, 4131, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark.
authors.forename: Søren
authors.initials: S
authors.lastname: Marker
authors.affiliation: Department of Intensive Care, 4131, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark.
authors.forename: Mette
authors.initials: M
authors.lastname: Krag
authors.affiliation: Department of Intensive Care, 4131, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark. mortenhylander@gmail.com.
authors.forename: Morten Hylander
authors.initials: MH
authors.lastname: Møller
mesh_terms: D000897:Anti-Ulcer Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016638:Critical Illness; D006635:Histamine H2 Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007362:Intensive Care Units; D064887:Observational Studies as Topic; D010438:Peptic Ulcer Hemorrhage / Q000209:etiology / Q000517:prevention & control; D017410:Practice Guidelines as Topic; D054328:Proton Pump Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D013276:Stomach Ulcer / Q000150:complications / Q000188:drug therapy* / Q000517:prevention & control*; D013312:Stress, Physiological
chemical_list: D000897:Anti-Ulcer Agents; D006635:Histamine H2 Antagonists; D054328:Proton Pump Inhibitors